Kavar Capital Partners Group, LLC Novo Nordisk A S Transaction History

Kavar Capital Partners Group, LLC

  • $630 Million
  • Q3 2024

A detailed history of Kavar Capital Partners Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Kavar Capital Partners Group, LLC holds 31,753 shares of NVO stock, worth $3.43 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
31,753
Previous 32,173 1.31%
Holding current value
$3.43 Million
Previous $4.59 Million 17.68%
% of portfolio
0.6%
Previous 0.83%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$119.07 - $145.42 $50,009 - $61,076
-420 Reduced 1.31%
31,753 $3.78 Million
Q2 2024

Jul 19, 2024
SELL
$122.71 - $146.91 $11,166 - $13,368
-91 Reduced 0.28%
32,173 $4.59 Million
Q1 2024

May 14, 2024
SELL
$102.11 - $135.92 $3.33 Million - $4.43 Million
-32,564 Reduced 50.23%
32,264 $4.14 Million
Q4 2023

Feb 14, 2024
BUY
$87.78 - $105.45 $2.84 Million - $3.41 Million
32,334 Added 99.51%
64,828 $6.71 Million
Q3 2023

Nov 06, 2023
BUY
$90.94 - $199.54 $1.42 Million - $3.11 Million
15,601 Added 92.35%
32,494 $2.96 Million
Q2 2023

Aug 07, 2023
SELL
$155.98 - $172.65 $2.41 Million - $2.67 Million
-15,479 Reduced 47.82%
16,893 $2.73 Million
Q1 2023

May 12, 2023
SELL
$132.34 - $159.14 $192,157 - $231,071
-1,452 Reduced 4.29%
32,372 $5.15 Million
Q4 2022

Feb 10, 2023
SELL
$102.55 - $135.33 $44,096 - $58,191
-430 Reduced 1.26%
33,824 $4.58 Million
Q3 2022

Nov 08, 2022
BUY
$95.28 - $116.93 $138,156 - $169,548
1,450 Added 4.42%
34,254 $3.41 Million
Q2 2022

Aug 09, 2022
SELL
$103.24 - $121.81 $67,106 - $79,176
-650 Reduced 1.94%
32,804 $3.66 Million
Q1 2022

May 09, 2022
SELL
$93.1 - $112.54 $17,689 - $21,382
-190 Reduced 0.56%
33,454 $3.72 Million
Q4 2021

Jan 27, 2022
SELL
$95.88 - $117.08 $6,711 - $8,195
-70 Reduced 0.21%
33,644 $3.77 Million
Q3 2021

Nov 01, 2021
SELL
$84.42 - $106.62 $21,105 - $26,655
-250 Reduced 0.74%
33,714 $3.24 Million
Q2 2021

Aug 02, 2021
SELL
$67.66 - $84.76 $40,596 - $50,856
-600 Reduced 1.74%
33,964 $2.85 Million
Q1 2021

May 13, 2021
SELL
$67.06 - $75.82 $57,001 - $64,446
-850 Reduced 2.4%
34,564 $2.33 Million
Q4 2020

Feb 05, 2021
BUY
$63.89 - $73.8 $2.26 Million - $2.61 Million
35,414 New
35,414 $2.47 Million

Others Institutions Holding NVO

# of Institutions
1,956
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Kavar Capital Partners Group, LLC Portfolio

Follow Kavar Capital Partners Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kavar Capital Partners Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kavar Capital Partners Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email